drugset / Trial / NCT00213109

Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment

NCT00213109

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type1 Diabetes Mellitus treated with insulin.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Miglitol Small molecule